Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Singular Genomics Systems Inc | OMIC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.4074 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.4074 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.3101 - 1.21 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.4074 | USD |
Singular Genomics Systems Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 30.09M | 73.38M | - | 2.91M | -94.82M | -1.29 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Singular Genomics Systems News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OMIC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3868 | 0.428 | 0.383 | 0.4016931 | 59,712 | 0.0206 | 5.33% |
| 1 Month | 0.5196 | 0.5325 | 0.36 | 0.4261919 | 116,915 | -0.1122 | -21.59% |
| 3 Months | 0.54 | 0.66 | 0.36 | 0.5088053 | 117,421 | -0.1326 | -24.56% |
| 6 Months | 0.3504 | 0.66 | 0.3101 | 0.4801222 | 352,972 | 0.057 | 16.27% |
| 1 Year | 1.00 | 1.21 | 0.3101 | 0.5705896 | 308,584 | -0.5926 | -59.26% |
| 3 Years | 29.00 | 33.37 | 0.3101 | 5.35 | 288,649 | -28.59 | -98.60% |
| 5 Years | 29.00 | 33.37 | 0.3101 | 5.35 | 288,649 | -28.59 | -98.60% |
Singular Genomics Systems Description
| Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Integrated Solution is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. |
